References
- Halls GA. The management of infections and antibiotic therapy: a European survey. J Antimicrob Chemother 1993; 31: 985–1000.
- Huchon GJ, Gialdroni-Grassi, Leophonte P et al. Initial antibiotic therapy for lower respiratory tract infection in the community: a European survey. Eur Respir J 1996; 9: 1590–95.
- Esposito S. Parenteral cephalosporin therapy in ambula-tory care. Drugs 2000; 59 (suppl 3) 19-28.
- Charlson ME, Pompei P,Ales KI et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373–83.
- Schaberg T, Gialdroni Grassi G, Huchon G et al. An analysis of decisions by European general practitioners to admit to hospital patients with lower respiratory tract infec-tions. Thorax 1996; 51: 1017–22.
- Cars O, Molstad S, Melander A. Variation in antibiotic use in the European Union. The Lancet 2001; 357: 1851–3.
- Keeley D. Guidelines for managing community acquired pneumonia in adults. BMJ 2002; 324: 436–7.
- An international collaborative surveillance study of com-munity-acquired bacterial LRTI pathogens: the Alexander Project. J Antimicrob Chemother 1996; 38: 1–155.
- Baskin MN, O'Rourke EJ, Fleisher GR. Outpatient treat-ment of febrile infants 28 to 89 days of age with intramuscu-lar administration of ceftriaxone. J Pediatr 1992; 120: 22–27.
- Strehl E, Kees F. Pharmacological properties of par-enteral cephalosporin. Rationale for ambulatory use. Drugs 2000; 59 (suppl 3): 9-18.
- Nathwani D. Sequential switch therapy for lower respi-ratory tract infections. Chest 1998; 113: 211S-218S.
- Mazzaglia G, Caputi AP, Rossi A et al. Exploring patient- and doctor-related variables associated with antibiotic prescribing for respiratory infections in primary care. Eur J Clin Pharmacol 2003; 59: 651–7.